Banque Cantonale Vaudoise’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Hold |
530
| – | – | ﹤0.01% | 690 |
|
|
2025
Q1 | $34K | Buy |
+530
| New | +$34K | ﹤0.01% | 725 |
|
|
2024
Q3 | $260K | Sell |
3,730
-1,204
| -24% | -$83.9K | 0.01% | 460 |
|
|
2024
Q2 | $320K | Sell |
4,934
-250
| -5% | -$16.2K | 0.01% | 511 |
|
|
2024
Q1 | $335K | Buy |
5,184
+1,454
| +39% | +$94K | 0.01% | 488 |
|
|
2023
Q4 | $246K | Hold |
3,730
| – | – | 0.01% | 550 |
|
|
2023
Q3 | $213K | Hold |
3,730
| – | – | 0.01% | 667 |
|
|
2023
Q2 | $229K | Sell |
3,730
-2,800
| -43% | -$172K | 0.01% | 683 |
|
|
2023
Q1 | $410K | Hold |
6,530
| – | – | 0.02% | 500 |
|
|
2022
Q4 | $415K | Buy |
6,530
+2,530
| +63% | +$161K | 0.02% | 493 |
|
|
2022
Q3 | $236K | Hold |
4,000
| – | – | 0.01% | 672 |
|
|
2022
Q2 | $231K | Hold |
4,000
| – | – | 0.01% | 696 |
|
|
2022
Q1 | $248K | Hold |
4,000
| – | – | 0.01% | 741 |
|
|
2021
Q4 | $285K | Buy |
4,000
+2,000
| +100% | +$143K | 0.01% | 743 |
|
|
2021
Q3 | $150K | Buy |
+2,000
| New | +$150K | 0.01% | 860 |
|